Back to companies

ALK-Abelló

DKNasdaq CopenhagenPharmaceuticals & Healthcare

ALK-Abelló

Revenue
DKK 5.5bn
FY2024
Operating income
—
FY2024
Employees
—
Founded
1923

Source: Wikidata (CC0)